TD Cowen reiterates Buy on Gap stock, cites business momentum By Investing.com

Shares trade at $22.31, down from $27.20 (a 17.3% decline over the past week) after Q4 results that were in line with estimates. Q4 EPS was $0.45 and revenue $4.2B, matching forecasts, while TD Cowen reiterated a Buy with a $32 price target but noted weaker fiscal Q4 comps, modest fiscal 2026 flow-through and softer fiscal Q1 guidance particularly on margins. Eight analysts have revised earnings down and tariff headwinds are pressuring margins (expected to ease in H2 FY26); current P/E is 12.77 and analyst targets range $22.60–$41.

Analysis

The market is effectively pricing a near-term margin shock into this apparel name, concentrating downside risk around one brand’s comp trajectory and tariff-driven cost pressure. That creates a binary setup: a tariff abatement and evidence of sustainable pricing (fewer promotions + AUR growth) would mechanically restore gross margin 200–300bps and re-rate the stock, while continued promotionaling or renewed tariff/headline risk prolongs the discount.

Beyond the company, a tariff rollback is a cross-sector positive for branded apparel with offshore sourcing but a relative negative for domestic manufacturers who benefited from protection; suppliers in Southeast Asia and freight/logistics firms will see order flow reallocate, tightening lead times and improving margin predictability for agile chains. Conversely, off-price operators (TJX) and fast-fashion players with ultra-low cost bases could see short-term share gains if consumer durable income weakens — a competitive dynamic that can mute margin recovery even if tariffs normalize.

Key catalysts to watch on a 1–12 month horizon are cadence of sequential comps at the budget brand, H1 vs H2 tariff guidance from management, and inventory aging metrics; each has outsized impact on working capital and markdown risk. Tail risks include a sustained consumer pullback into essentials (6–18 months) or new trade measures that ratchet input costs higher — either would require re-pricing of the recovery case and likely compress multiples further.

Key Decisions for Investors

• Long GAP equity (6–12 month horizon), tactical size 2–3% portfolio: thesis is asymmetric — if tariffs abate and Old Navy comps stabilize, expect meaningful margin recovery and a >40% upside to fair-value; downside risk ~30–35% if comps deteriorate further. Use a hard stop or hedge if two consecutive comp misses occur.
• Buy a 12–18 month call spread (buy long-dated call / sell higher strike call) to play H2 margin recovery: limited cost, capped upside but 3x+ return if the stock re-rates with margin expansion. Enter on any 5–10% pullback to improve IRR and keep position size small vs outright equity.
• Relative-value pair: long GAP / short TGT (equal notional, 6–12 months) to isolate brand/comps recovery vs broad retail demand — this hedges beta and targets 15–25% relative outperformance if Gap's AUR/promotion mix holds while discounters see weaker re-pricing power.
• Short-dated protective puts (3–6 months) as insurance ahead of tariff announcements or the next quarterly guide: inexpensive hedge to cap near-term drawdown from a negative policy surprise; sell or let expire if management signals H2 tariff relief and margin pass-through.